Dianthus Therapeutics ratios data for the quarter ended Dec 2025. These financial ratios cover 31 quarters of results from Jun 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||
| EBT Margin | -668.20% | -855.57% | -1,415.40% | -1,108.90% | -1,594.37% | -2,300.22% | -2,050.11% | -1,192.38% | -1,171.96% | -2,106.03% | -2,838.61% | -16,333.68% | -9,250.00% | ||||||||||||||||||
| EBIT Margin | -703.67% | -910.04% | -1,536.60% | -1,177.60% | -1,705.52% | -2,835.01% | -2,041.65% | -1,191.84% | -1,376.61% | -2,406.94% | -2,852.71% | -18,096.89% | -10,173.74% | ||||||||||||||||||
| EBITDA Margin | -703.67% | -910.04% | -1,536.60% | -1,177.60% | -1,705.52% | -2,835.01% | -2,041.65% | -1,191.84% | -1,376.61% | -2,406.94% | -2,852.71% | -18,096.89% | -10,173.74% | ||||||||||||||||||
| Operating Margin | -703.67% | -910.04% | -1,536.60% | -1,177.60% | -1,705.52% | -2,835.01% | -2,041.65% | -1,191.84% | -1,376.61% | -2,406.94% | -2,852.71% | -18,096.89% | -10,173.74% | ||||||||||||||||||
| Net Margin | -668.20% | -855.57% | -1,415.40% | -1,108.90% | -1,594.37% | -2,300.22% | -2,050.11% | -1,192.38% | -1,171.96% | -2,106.03% | -2,838.61% | -16,333.68% | -9,250.00% | ||||||||||||||||||
| FCF Margin | 1,399.91% | -755.74% | -2,059.60% | -475.20% | -1,088.42% | -2,596.06% | -1,713.16% | -780.73% | -980.29% | -2,072.02% | -2,377.82% | -12,403.11% | -7,717.17% | ||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 153.12M | 182.50M | 213.31M | 198.09M | 192.16M | 184.75M | 169.62M | 123.62M | 83.28M | 81.04M | 135.55M | 185.93M | 280.93M | 375.71M | 361.60M | 364.13M | 361.29M | 337.33M | 451.76M | 554.18M | |||||||||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.02 | 0.03 | 0.05 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | ||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||
| Price to EarningsP/E | -32.90 | -33.80 | -24.55 | -13.50 | -7.43 | -4.09 | -10.89 | -2.41 | -6.77 | -4.16 | -3.63 | -5.10 | -49.14 | -34.20 | -31.59 | -24.29 | -17.65 | -19.02 | -46.04 | ||||||||||||
| Price to SalesP/S | 72.79 | 20.64 | 95.83 | 46.10 | 57.80 | 117.28 | 0.00M | 407.75 | 370.19 | 511.55 | 501.09 | 0.00M | 0.00M | ||||||||||||||||||
| Price to BookP/B | 4.46 | 2.82 | 2.26 | -15.10 | -7.73 | -2.57 | -2.46 | -0.55 | -0.94 | -0.75 | 0.30 | 0.32 | 2.36 | 2.12 | 2.38 | 1.92 | 1.77 | 1.98 | 3.09 | 3.58 | |||||||||||
| Enterprise Value | 443.17M | 364.41M | 235.28M | 83.55M | 13.91M | -68.87M | -20.75M | -51.23M | -4.98M | -9.14M | -136.46M | -120.12M | 503.42M | 398.93M | 522.93M | 403.07M | 319.53M | 342.06M | 1,283.71M | 1,361.74M | |||||||||||
| EV to EBIT | -23.70 | -20.69 | -12.90 | -4.15 | -0.58 | 3.81 | 2.51 | 4.79 | 0.65 | 0.78 | 8.66 | 9.27 | -28.21 | -17.97 | -17.49 | -12.63 | -9.63 | -9.79 | -31.86 | ||||||||||||
| EV to EBITDA | -23.70 | -20.69 | -12.90 | -4.15 | -0.58 | 3.81 | 2.51 | 4.79 | 0.65 | 0.78 | 8.66 | 9.27 | -28.21 | -17.97 | -17.49 | -12.63 | -9.63 | -9.79 | -31.86 | ||||||||||||
| Market Capitalization | 575.46M | 572.22M | 427.90M | 260.48M | 170.52M | 70.56M | 85.38M | 24.26M | 47.91M | 46.10M | 53.41M | 53.60M | 880.46M | 759.63M | 804.05M | 678.31M | 582.76M | 599.45M | 1,686.33M | 1,766.04M | |||||||||||
| Price to FCFP/FCF | -34.29 | -40.82 | -29.94 | -16.59 | -8.63 | -4.15 | 5.20 | -2.73 | -4.65 | -9.70 | -5.31 | -4.52 | -58.80 | -52.23 | -37.76 | -24.69 | -21.07 | -25.04 | -55.18 | ||||||||||||
| EV to FCF | -26.41 | -26.00 | -16.46 | -5.32 | -0.70 | 4.06 | -1.26 | 5.77 | 0.48 | 1.92 | 13.57 | 10.12 | -33.62 | -27.43 | -24.56 | -14.67 | -11.55 | -14.29 | -42.01 | ||||||||||||
| EV to CFO | -26.42 | -28.03 | -16.73 | -5.33 | -0.70 | 4.09 | -1.27 | 5.79 | 0.48 | 1.93 | 13.66 | 10.13 | -33.69 | -27.46 | -24.59 | -14.69 | -11.56 | -14.32 | -42.01 | ||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -703.67% | -910.04% | -1,536.60% | -1,177.60% | -1,705.52% | -2,835.01% | -2,041.65% | -1,191.84% | -1,376.61% | -2,406.94% | -2,852.71% | -18,096.89% | -10,173.74% | ||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -52.92% | -43.03% | -36.24% | -39.89% | -44.83% | -46.28% | -44.87% | -52.75% | -57.85% | -49.87% | -37.49% | -27.32% | -21.45% | -18.80% | -23.97% | -29.47% | -34.04% | -40.95% | -32.79% | ||||||||||||
| Return on Assets [ROA]ROA | -47.29% | -38.50% | -32.82% | -35.91% | -39.86% | -41.64% | -39.71% | -47.01% | -50.72% | -44.49% | -31.69% | -23.35% | -19.31% | -17.40% | -21.04% | -25.68% | -30.06% | -34.96% | -28.58% |